|
Apr 25
|
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
|
|
Apr 25
|
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?
|
|
Apr 24
|
Pharming announces positive recommendation from NICE for Joenja
|
|
Apr 24
|
Pharming Group to report first quarter 2025 financial results on May 8
|
|
Apr 23
|
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
|
|
Apr 15
|
European Opportunities: 3 Penny Stocks With Market Caps Larger Than €10M
|
|
Mar 14
|
Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Mar 14
|
3 European Penny Stocks With Market Caps Over €300M
|
|
Mar 14
|
Pharming Group Full Year 2024 Earnings: EPS Beats Expectations
|
|
Mar 13
|
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
|
|
Feb 28
|
Pharming Group to participate in March investor conference
|
|
Feb 27
|
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
|
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|
|
Feb 11
|
High Growth Tech And These 3 Dynamic Stocks with Promising Expansion
|
|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
|
Apr 4
|
Pharming Group announces the 2024 Annual General Meeting of Shareholders
|
|
Apr 4
|
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
|
|
Apr 3
|
Pharming Group to participate in April investor conferences
|
|
Feb 29
|
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
|
|
Aug 9
|
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
|